Matthew Reade Miller

Director Matthew Reade Miller buys 10,600 shares of GRNT at $4.75; stock down -29.3% from 52-week high amid $47.0M net loss.

Matthew Reade Miller purchased 10,600 shares at $4.75 on 2026-06-09, increasing his stake by 10,600 shares to 1,360,813 shares total. The stock is currently trading -29.3% from its 52-week high of $6.72 and has declined -5.0% over 30 days and -6.3% over 90 days. His prior trades at GRNT show a mixed record: of his 5 prior buys at this ticker, only 1 of 5 achieved positive 90-day returns, while his cross-ticker track record across 20 buys shows an average 90-day return of -2.7% with a 35.00% win rate. The company reported a net loss of $47.0M in the latest quarter against $128.3M in revenue, though annual revenue growth reached +18.5%. This purchase occurs as the stock remains depressed from recent highs, and the director's historical timing pattern at this specific ticker has been largely unsuccessful at capturing recoveries.

Director Matthew Reade purchases 18,180 shares as stock trades well below 52-week highs, continuing a consistent buying pattern despite mixed prior trade timing.

Director Matthew Reade added to his position in Granite Ridge Resources with this open-market purchase, marking his sixth buy of company shares within the three-year window and extending a streak of 30 consecutive open-market purchases across all his holdings without a single sale. The timing reflects a cautious investor stance: the stock is trading significantly below its 52-week high, having declined in recent weeks, while Granite Ridge remains a profitable, growing company by annual metrics, though the latest quarterly results showed a loss. Reade's track record at this specific ticker is mixed—of five prior buys at Granite Ridge, three saw the stock appreciate over the subsequent 90-day period while two saw declines, suggesting he has been neither consistently early nor consistently late in his purchases. The current purchase at depressed levels continues his repeat-buyer approach, though whether this accumulation into weakness will prove well-timed remains uncertain given his historical 50/50 success rate on timing at this stock.

Director Miller Matthew Reade buys 658 shares of GRNT at $5.15; cluster pattern with 4 other insiders buying in past 14 days

Director Miller Matthew Reade purchased 658 shares at $5.15 on 2026-03-13, adding to a position of 1,328,839 shares post-transaction. The transaction occurs within a cluster pattern where 4 other insiders have also bought GRNT within the past 14 days, suggesting coordinated or coincident confidence. At the company level, fundamentals appear solid with Revenue $112,671,000.00, Net income $14,523,000.00, and annual revenue growth of +18.5%, alongside a P/E of 16.09. However, Reade's historical record at this ticker shows limited success: only 1 of his 4 prior measurable GRNT purchases achieved positive 90-day returns, with two purchases posting 90-day losses of -5.6% and -5.2%. The current stock price of $5.31 reflects a 30-day gain of +5.2% but remains -20.3% from its 52-week high of $6.66, placing the purchase in a depressed context relative to recent range.

Director Matthew Reade Miller bought 10,000 shares of GRNT at $5.10; stock now at $5.07, -23.9% from high.

Matthew Reade Miller, a director, purchased 10,000 shares at $5.10 on 2026-03-10, expanding his holdings to 1.33M shares. The purchase occurs as GRNT trades near depressed levels relative to its 52-week high ($6.66), though company fundamentals show solid operational performance: $112.7M quarterly revenue, $14.5M net income, and 18.5% annual revenue growth at a 15.36 P/E ratio. However, his prior trading history at GRNT is cautionary—across 5 prior buys at this ticker, he achieved 0 of 4 measurable 90-day positive outcomes, with losses ranging from -1.3% to -10.2%. His cross-ticker track record (20 prior buys, 36.84% 90-day win rate, -2.1% average 90-day return) does not support a pattern of well-timed entry points. The buy is part of a cluster pattern with 3 other insiders purchasing within 14 days, a signal of coordinated interest at current prices, though without subsequent insider transactions or revised guidance, the cluster's significance remains limited.

Director Matthew Reade bought 648 shares at $5.13 on 2025-12-15; now trading -29.6% from 52-week high at $4.85.

Director Matthew Reade purchased 648 shares at $5.13 on 2025-12-15, a relatively small acquisition of $3,324.24 that increased his holdings from 1,297,518 to 1,298,166 shares (a +0.0% net change). This buy occurred as GRNT stock trades at $4.85, down -29.6% from its 52-week high of $6.89 and off -5.3% over the past month. Reade's same-ticker purchase history at GRNT shows a poor timing record: his prior 4 measured buys all produced negative 90-day returns, with 0 of 4 being well-timed at the 90-day mark (outcomes ranging from -12.0% to -0.6%). His broader cross-ticker buy track record over 20 prior open-market purchases averaged only +1.5% at 30 days and -2.0% at 90 days, with a 90-day win rate of just 42.11%. The company's fundamentals show stable profitability (net income $14,523,000.00 on revenue $112,671,000.00) but annual revenue contracted by -3.6% year-over-year, and the stock's extended decline from recent highs warrants observation of whether subsequent quarters reverse the downtrend.

Director Matthew Reade Miller buys 9,388 shares of GRNT at $5.33 on 2025-12-04; cluster buy pattern with 2 other insiders in 14 days

Director Matthew Reade Miller purchased 9,388 shares at $5.33, adding 0.7% to his 1.30M share position, amid a cluster pattern with 2 other insiders buying within 14 days. At the current price of $5.42, the purchase sits -21.3% from the 52-week high, though the 30-day price change is +2.6%. However, his prior trades at GRNT show mixed timing outcomes: only 1 of 4 prior measurable buys produced positive 90-day returns, with a 90-day timing score of 25% (1 win out of 4 trades). His cross-ticker track record (20 prior buys across all tickers) shows an average 90-day return of -1.3% with a 47.37% win rate, suggesting limited predictive power. The cluster buy pattern warrants attention, but the insider's own historical execution at this ticker has not been consistently well-timed.

Director Matthew Reade Miller purchased 600 shares of GRNT at $5.35, bringing holdings to 1,284,664 shares; stock currently at $5.52, up 4.0% in 30 days.

Matthew Reade Miller, a director at Granite Ridge Resources, purchased 600 shares on 2025-09-15 at $5.35, a modest addition to his existing 1,284,064-share position. The stock is currently trading at $5.52, representing a $0.17 gain from the purchase price and a 30-day gain of 4.0%, though it remains 19.9% below its 52-week high. His recent trading history at GRNT shows mixed outcomes: of five prior purchases at this ticker, only one exhibited a positive 90-day return, and the most recent buy on 2025-08-12 has shown only 0.9% gain over 30 days. While his cross-ticker track record shows a 52.63% win rate with an average 30-day return of 2.6%, his same-ticker results at GRNT have been predominantly negative over longer horizons, suggesting this director's buying activity has not consistently preceded price appreciation at this company.

Director Miller Matthew Reade buys 18,700 shares of GRNT at $5.36; modest accumulation amid cluster activity by 2 other insiders within 14 days.

Miller Matthew Reade purchased 18,700 shares at $5.36 on 2025-08-12, increasing his holdings to 1.28M shares (+1.5% from prior position). The transaction occurs within a cluster pattern: 2 other insiders also bought within the past 14 days. However, the director's prior timing at this ticker has been mixed—only 1 of 3 prior buys at GRNT resulted in positive 90-day returns, including a -15.2% 30-day loss on his 2025-03-14 purchase and a -4.3% 90-day result on his 2024-12-16 buy. The stock is currently 21.9% below its 52-week high, down 6.9% over 30 days, and trades at a P/E of 21.52 with annual revenue declining 3.6% year-over-year. The modest transaction size and persistent pattern of underwater trades at this ticker merit attention, though the concurrent cluster activity may indicate coordinated insider perspective on recent valuation.

Director Miller Matthew Reade buys 544 shares of GRNT at $5.98; cluster buy pattern with 2 others in 14 days, but 1-of-4 timing success at same ticker.

Miller Matthew Reade (Director) purchased 544 shares of Granite Ridge Resources at $5.98 on 2025-06-13 for a total value of $3,253.12, increasing his holdings to 1,262,421 shares. This buy occurs within a cluster context—2 other insiders also acquired shares within the past 14 days—which may suggest broader insider confidence. However, the director's historical performance at this ticker shows limited timing success: his prior 4 measurable trades at GRNT produced only 1 well-timed outcome at the 90-day mark, with mixed results including a 90-day return of -4.3% and -13.3% on earlier buys. His cross-ticker track record is stronger (63.16% win rate, 90d avg +5.6%), but the same-ticker pattern—particularly the 90-day underperformance on 2 of 4 prior buys—suggests prior timing challenges specific to this company. The current price of $6.04 reflects a gain of roughly 1% from the transaction price, and the stock remains -14.3% from its 52-week high.

Director Matthew Reade Miller bought 17,000 shares of GRNT at $5.98 on 2025-06-16, joining cluster of 2 other insiders buying within 14 days

Director Matthew Reade Miller purchased 17,000 shares at $5.98 on 2025-06-16, adding to his existing 1.26M share position—a modest 1.4% increase. This purchase occurred as part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated or momentum-based activity among the board. At the same ticker, Miller's prior 4 measurable trades showed only 1 well-timed outcome at the 90-day mark, indicating mixed historical accuracy in GRNT timing; his cross-ticker track record shows 63.16% win rate over 90 days with average +5.6% returns, though this does not necessarily predict performance on GRNT. The stock is currently at $6.00, 14.9% below its 52-week high and up 6.2% over 30 days, placing the transaction near recent momentum inflection points that warrant monitoring for both follow-through and fundamental alignment.